Published in Blood Weekly, September 21st, 2000
"Ewing's sarcoma is a childhood tumor characterized by a t(11,22) [mutation] in most patients," reported Margret Merino and colleagues from the U.S. National Institutes of Health, Maryland, and the Memorial Sloan-Kettering Cancer Center in New York.
"Because survival remains suboptimal with standard therapy, many patients receive autologous stem cell transplant and trials investigating adoptive transfer of autologous T cells in the context of immune therapy are underway. However, approximately 50% of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.